Medicare Home Infusion Therapy Coverage Act of 2007

Seeking comprehensive Medicare coverage of home infusion therapy (Medicare Home Infusion Therapy Coverage Act (H.R. 2567, S. 3505) -- all provisions) Medicare reform issues pertaining to homecare and infusion therapy Medicare competitive bidding issues

Client expense: Not reported · Firm income: $10,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare coverage issues H. R. 2567, Medicare Home Infusion Therapy Coverage Act of 2007 S. 870, Medicare Home Infusion Therapy Consolidated Coverage Act of 2007 S. 3505, Medicare Home Infusion Therapy Coverage Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

H.R. 2567, Medicare Home Infusion Therapy Act. To amend title XVIII of the Social Security Act to provide for the coverage of home infusion therapy under the Medicare Program. S. 3505, Medicare Home Infusion Therapy Act. To amend title XVIII of the Social Security Act to provide for the coverage of home infusion therapy under the Medicare Program.

Client expense: $32,187 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Competitive Bidding, H.R. 6252/S. 3144: Medicare DMEPOS Competitive Acquisition Reform Act H.R. 2567/S. 3505: Medicare Home Infusion Therapy Coverage Medicare Program Regulation Re: Part B Home Oxygen Therapy 42 CFR 414.226(g)(2)

Client expense: $120,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

"FY 2009 Inpatient Prospective Payment System (IPPS) rule" urging CMS to withdraw a proposal to eliminate the Medicare indirect medical education (IME) adjustment for teaching hospitals that is provided under the Medicare capital payment system. Preserving Access to Healthcare (PATH) Act of 2008 (S. 3656/H.R. 7241) which would retroactively delay for six months a two-year phase-out of capital IME payments for teaching hospitals that was implemented on October 1, 2008. Hospital wage index reclassification and resolution of regional disparity. Issues related to the reduction of the annual disproportionate share (DSH) payment and problems with the SSI formula calculation. Expanding Medicare payment rules for stroke related telehealth services to include urban areas and the "Medicare Home Infusion Therapy Coverage Act of 2008" (S.3505/HR2567) to provide coverage for infusion-related services, supplies and equipment under Medicare Part B.

Client expense: $303,160 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 2567, "To amend title XVIII of the Social Security Act to provide for the coverage of home infusion therapy under the Medicare Program," provisions related to Medicare Parts A (Hospital Insurance), B (Medical Insurance Coverage) & D (Prescription Drugs). S. 2464, Medicare Improvement Act of 2007, All provisions H.R. 4704, Medicare Improvement Act of 2007, All provisions H.R. 4992, Medicare Improvement Act of 2007, All provisions

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 2567, Medicare Home Infusion Benefit Coordination. Medicare reimbursement for genetic counseling.

Client expense: $200,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

Medicare Part D, Antitrust Exemption for Independent Pharmacies, IVIG Payments, Competitive Acquuisition Program for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 2567 and S 3505 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2914 and S 2990 - Medicare IVIG Access Act of 2008; all aspects

Client expense: $780,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Health Information Technology, Electronic Prescribing, Comparative Effectiveness, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Carve-out of Generic Drugs from State Generic Substituion Laws HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S. 3505 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2008; all aspects HR 2914 and S 2990 - Medicare IVIG Access Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 6357- Protecting Records, Optimizing Treatment and Easing Communcations through Healthcare Technology PRO(TECH)T Act of 2008; all aspects HR 6898 - Health-e-Information Technology Act of 2008; all aspects S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects

Client expense: $780,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Afforadable Generics Act; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S. 3505 and S. 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2008; all aspects HR 2914 and S. 2990 - Medicare IVIG Acces Act of 2007; all aspects HR. 3800 - Promoting Health Information Technology Act; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 6357 - Protecting Records, Optimimizing Treatment and Easing Communications through Healthcare Technology (PRO[TECH]HIT) Act of 2008; all aspects HR 6898 - Health-e-Information Technology Act of 2008; all aspects S 976 - Genomics and Personlized Medicine Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S 1814 - Health Information Privacy and Security Act; all aspects

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare Part D, Antitrust Exemption for Independent Pharmacies, IVIG Payments, Medicare Demonstration Projects for Durable Medical Equipment HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 2567 and S. 3505 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2914 and S 2990 - Medicaer IVIG Access Act of 2008; all aspects

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 S 3, Medicare Prescription Drug Price Negotiation Act of 2007 HR 1014 - Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid HR 3963 - Childrens Health Insurance Program Extension & Improvement S 558 - Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid HR 1424, Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid Medicare prescription drug benefit implementation (no bills) - retain Medicaid rebates (no bills) - retain the general issues section Medicaid coverage (no bills) Average Manufacturer Price Regulation HR. 3162, Childrens Health and Medicare Protection Act 2007 HR. 976/2963, Childrens Health Insurance Program Reauthorization 2007 HR. 118, To amend part D of title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate prices for part D covered drugs for Medicare beneficiaries 2/07 H.R. 6331 Medicare Improvements for Patients & Providers Act HR 2567, Medicare Home Infusion Therapy Coverage Act of 2007

Client expense: $3,070,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)

Medicare coverage issues H. R. 2567, Medicare Home Infusion Therapy Coverage Act of 2007 S. 870, Medicare Home Infusion Therapy Consolidated Coverage Act of 2007 S. 3505, Medicare Home Infusion Therapy Coverage Act of 2008 H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007

Client expense: $164,173 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Seeking comprehensive Medicare coverage of home infusion therapy (Medicare Home Infusion Therapy Coverage Act (H.R. 2567) -- all provisions) Medicare reform issues pertaining to homecare and infusion therapy Medicare competitive bidding issues [Medicare Improvements for Patients and Providers Act (H.R. 6331) -- Sec. 154]

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 S 3, Medicare Prescription Drug Price Negotiation Act of 2007 HR 1014 - Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid HR 3963 - Childrens Health Insurance Program Extension & Improvement S 558 - Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid HR 1424, Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid Medicare prescription drug benefit implementation (no bills) - retain Medicaid rebates (no bills) - retain the general issues section Medicaid coverage (no bills) Average Manufacturer Price Regulation HR. 3162, Childrens Health and Medicare Protection Act 2007 HR. 976/2963, Childrens Health Insurance Program Reauthorization 2007 HR. 118, To amend part D of title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate prices for part D covered drugs for Medicare beneficiaries 2/07 H.R. 6331 Medicare Improvements for Patients & Providers Act HR 2567, Medicare Home Infusion Therapy Coverage Act of 2007

Client expense: $3,060,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)

H.R. 2567, Medicare Home Infusion Therapy Act. To amend title XVIII of the Social Security Act to provide for the coverage of home infusion therapy under the Medicare Program. S. 3505, Medicare Home Infusion Therapy Act. to amend title XVIII of the Social Security Act to provide for the coverage of home infusion therapy under the Medicare Program.

Client expense: $51,508 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare coverage issues H. R. 2567, Medicare Home Infusion Therapy Coverage Act of 2007 S. 870, Medicare Home Infusion Therapy Consolidated Coverage Act of 2007 S. 3505, Medicare Home Infusion Therapy Coverage Act of 2008 H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

"FY 2009 Inpatient Prospective Payment System (IPPS) rule" urging CMS to withdraw a proposal to eliminate the Medicare indirect medical education (IME) adjustment for teaching hospitals that is provided under the Medicare capital payment system. Preserving Access to Healthcare (PATH) Act of 2008 (S. 3656/H.R. 7241) which would retroactively delay for six months a two-year phase-out of capital IME payments for teaching hospitals that was implemented on October 1, 2008. Hospital wage index reclassification and resolution of regional disparity. Issues related to the reduction of the annual disproportionate share (DSH) payment and problems with the SSI formula calculation. Expanding Medicare payment rules for stroke related telehealth services to include urban areas and the "Medicare Home Infusion Therapy Coverage Act of 2008" (S.3505/HR2567) to provide coverage for infusion-related services, supplies and equipment under Medicare Part B.

Client expense: $270,000 · Firm income: Not reported

Government targets: Air Force, Dept of, Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

HR 2567, "To amend title XVIII of the Social Security Act to provide for the coverage of home infusion therapy under the Medicare Program," provisions related to Medicare Parts A (Hospital Insurance), B (Medical Insurance Coverage) & D (Prescription Drugs). S. 2464, Medicare Improvement Act of 2007, All provisions H.R. 4704, Medicare Improvement Act of 2007, All provisions H.R. 4992, Medicare Improvement Act of 2007, All provisions

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare Part D, Prompt Payment of Pharmacy Claims, Antitrust Exemption for Independent Pharmacists, IVIG Payments, Medicare Demonstration Project for Durable Medical Equipment HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 - Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 6252 and S 3144 - Medicare DMEPOS Competitive Acquisition Reform Act of 2008; all aspects HR 6331 - Medicare Improvement for Patients and Providers Act of 2008; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 2219 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects S 3101 - Medicare Improvements for Patients and Providers Act of 2008; all aspects S 3118 - Preserving Access to Medicare Act of 2008; sections 132, 145, 161-167

Client expense: $434,097 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Health Information Technology, Electronic Prescribing, Inappropriate use of Human Growth Hormone, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Carve-out of Generic Drugs from State Generic Substitution Laws HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 5683 - Government Accountability Office Act of 2008, section 721 HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects HR 6898 - Health e-Information Technology Act; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

Client expense: $434,097 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 - Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 6252 and S 3144 - Medicare DMEPOS Competitive Acquisition Reform Act of 2008; all aspects HR 6331 - Medicare Improvement for Patients and Providers Act of 2008; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 2219 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects S 3101 - Medicare Improvements for Patients and Providers Act of 2008; all aspects S 3118 - Preserving Access to Medicare Act of 2008; sections 132, 145, 161-167

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE

HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 5683 - Government Accountability Office Act of 2008, section 721 HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects HR 6898 - Health e-Information Technology Act; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE

Medicare coverage issues H. R. 2567, Medicare Home Infusion Therapy Coverage Act of 2007 S. 870, Medicare Home Infusion Therapy Consolidated Coverage Act of 2007 H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Seeking comprehensive Medicare coverage of home infusion therapy (Medicare Home Infusion Therapy Coverage Act (H.R. 2567) -- all provisions) Medicare reform issues pertaining to homecare and infusion therapy Medicare competitive bidding issues [Medicare Improvements for Patients and Providers Act (H.R. 6331) -- Sec. 154]

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 2567, Medicare Home Infusion Therapy Act. To amend title XVIII of the Social Security Act to provide for the coverage of home infusion therapy under the Medicare Program.

Client expense: $59,701 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare coverage issues H. R. 2567 Medicare Home Infusion Therapy Coverage Act of 2007 S. 870, Medicare Home Infusion Therapy Consolidated Coverage Act of 2007 H. R. 6331, Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007

Client expense: $125,920 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Health Information Technology, Electronic Prescribing, Genetic Nondiscrimination, Inappropriate use of Human Growth Hormone, Medicare Part D Contract Disclsoure Requirements, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Off-Label Use of Prescription Drugs, Over-the-Counter Drug Dispersement, Carve-out of Generic Drugs from State Medicaid Generic Substitution Laws HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2008; Title I HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 5683 - Government Accountability Office Act of 2008, section 721 HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

Client expense: $508,492 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE

Medicare Part D, Prompt Payment of Pharmacy Claims, Antitrust Exemption for Independent Pharmacies, IVIG Payments, Tracking the Pedigree of Prescription Drugs, Reimportation of Prescription Drugs, Medicare Demonstration Project for Durable Medical Equipment HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 - Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 6252 and S 3144 - Medicare DMEPOS Competitive Acquisition Reform Act of 2008; all aspects HR 6331 - Medicare Improvement for Patients and Providers Act of 2008; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 2219 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects S 3101 - Medicare Improvements for Patients and Providers Act of 2008; all aspects S 3118 - Preserving Access to Medicare Act of 2008; sections 132, 145, 161-167

Client expense: $508,492 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE

HR 2567, "To amend title XVIII of the Social Security Act to provide for the coverage of home infusion therapy under the Medicare Program," provisions related to Medicare Parts A (Hospital Insurance), B (Medical Insurance Coverage) & D (Prescription Drugs).

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 - Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 6252 and S 3144 - Medicare DMEPOS Competitive Acquisition Reform Act of 2008; all aspects HR 6331 - Medicare Improvement for Patients and Providers Act of 2008; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 2219 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects S 3101 - Medicare Improvements for Patients and Providers Act of 2008; all aspects S 3118 - Craig Thomas Rural Hospital and Provider Equity Act of 2008; sections 132, 145, 161-167

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2007; Title I HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 5683 - Government Accountability Office Act of 2008, section 721 HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c); all aspects S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

HR 2567, "To amend title XVIII of the Social Security Act to provide for the coverage of home infusion therapy under the Medicare Program," provisions related to Medicare Parts A (Hospital Insurance), B (Medical Insurance Coverage) & D (Prescription Drugs).

Client expense: Not reported · Firm income: $40,000

Medicare Part D, Prompt Payment to Pharmacies, Antitrust Exemption for Pharmacists, IVIG Payments, Tracking or Pedigree of Prescription Drugs, Reimportation of Prescription Drugs, Medicare Demonstration Project for Durable Medical Equipment HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 Pharmaceutical Market Access Act of 2007; all aspects S 273 Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 Access to Medicare Data Act of 2007; all aspects S 2219 Medicare Prescription Drug Savings and Choice Act of 2007; all aspects

Client expense: Not reported · Firm income: $60,000

Health information technology, Electronic prescribing, Genetic Nondiscrimination, Inappropriate Use of Human Growth Hormone, Contract Disclosure Regulations, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Off-label Use of Prescription Drugs HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2007; Title I HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects H.R. 5629 - Pathway for Biosimilars Act; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c); all aspects S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects

Client expense: Not reported · Firm income: $60,000

H.R. 2567, Medicare Home Infusion Therapy Act. To amend title XVIII of the Social Security Act to provide for the coverage of home infusion therapy under the Medicare Program.

Client expense: $41,219 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1663: Medicare Mental Health Modernization Act S 1103: Helping Fill the Medicare Rx Gap Act S 1108: Medicare Part D Outreach and Enrollment Enhancement Act S 1701: TMA/Medicare Advantage S 1883 Accountability and Transparency in Medicare Marketing Act of 2007 S 2499 Medicare, Medicaid & SCHIP Extension Act of 2007. S 1218 Medicare for All Act HR 2034 Medicare for All Act S 130 Medicare Cost Contract Extension & Retirement Act of 2007 S3 Medicare Prescription Drug Price Negotiation Act of 2007 HR 4 Medicare Prescription Drug Price Negotiation Act of 2007 HR 976 Children's Health Insurance Program Reauthorization Act of 2007 HR 971 Community Pharmacy Fairness Act of 2007 Medicare; Medicare Advantage; Medicare Part D; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act"; Medicare Electronic Helath Records; Pay for Performance S. 2785: Save Medicare Act of 2008 H.R. 4296/S. 2408: Medicare Electronic Medication and Safety Protection (E-MEDS) Act H.R. 5613: Protecting the Medicaid Safety Net Act of 2008; Comparative Effectiveness; Medicare Reform HR 1474 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 HR 2567 Medicare Home Infusion Therapy Coverage Act of 2007 HR 2606 340B Program Improvement and Integrity Act of 2007 HR 2914 Medicare IVIG Access Act of 2007 HR 3932 Medicare Prescription Drug Savings and Choice Act of 2007 S 870 Medicare Home Infusion Therapy Consolidated Coverage Act of 2007 S 1376 340B Program Improvement and Integrity Act of 2007 S 1507 Access to Medicare Data Act of 2007 S 1544 Medicare Quality Enhancement Act of 2007 Competitive Bidding Contract Disclosure Regulations 340B Program H.R. 2945 Medicare Advantage Truth in Advertising Act H.Con Res. 312 Budget Resolution S. 1954 Pharmacy Access Improvement Act S. 2408 Medicare Electronic Medication and Safety Protection Act H.Con Res. 70 Budget Resolution S 1893/HR 976 Children's Health Insurance Program Reauthorization Act of 2007 H.R. 3162: Children's Health and Medicare Protection Act of 2007 S. 2499 Medicare, Medicaid & SCHIP Extension Act of 2007.

Client expense: Not reported · Firm income: $75,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Ensuring comprehensive Medicare coverage of home infusion therapy (Medicare Home Infusion Therapy Coverage Act (H.R. 2567) -- all provisions) Medicare reform issues pertaining to homecare and infusion therapy

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Rural health, telehealth, medicare and state's health insurance program legislation (HR 2567)

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Rural health, telehealth, medicare and state's health insurance program legislation (HR 2567)

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare Part D, Prompt Payment to Pharamcies, Antitrust Exemption for Pharmacists, IVIG Payments, Tracking or Pedigree of Prescription Drugs, Reimportation of Prescription Drugs, Medicare Demonstration Project for Durable Medical Equipment. HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 Pharmaceutical Market Access Act of 2007; all aspects S 273 Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 Access to Medicare Data Act of 2007; all aspects S 2219 Medicare Prescription Drug Savings and Choice Act of 2007; all aspects

Client expense: $880,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE

Health Information Technology, Electronic Prescribing, Genetic Nondiscrimination, Inappropriate use of Human Growth Hormone, Contract Dislcosure Regulations, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Off-Label Use of Prescription Drugs. HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2007; Title I HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects H.R. 5629 - Pathway for Biosimilars Act; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c); all aspects S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

Client expense: $880,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE

HR 1474 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 HR 2567 Medicare Home Infusion Therapy Coverage Act of 2007 HR 2606 340B Program Improvement and Integrity Act of 2007 HR 2914 Medicare IVIG Access Act of 2007 HR 3932 Medicare Prescription Drug Savings and Choice Act of 2007 HR 4296 Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 S 870 Medicare Home Infusion Therapy Consolidated Coverage Act of 2007 S 1376 340B Program Improvement and Integrity Act of 2007 S 1507 Access to Medicare Data Act of 2007 S 1544 Medicare Quality Enhancement Act of 2007 Competitive Bidding Contract Disclosure Regulations Comparative Effectiveness 340B Program

Client expense: Not reported · Firm income: $75,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare coverage issues H. R. 2567, Medicare Home Infusion Therapy Coverage Act of 2007 S. 870, Medicare Home Infusion Therapy Consolidated Coverage Act of 2007

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Medicare coverage issues H.R. 2567, Medicare Home Infusion Therapy Coverage Act of 2007 S. 870, Medciare Home Infusion Therapy Consolidated Coverage Act of 2007

Client expense: $131,330 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)